Ronald S. Go

发表

W. Choi, R. Gascoyne, G. Slack, 2013 .

W. Choi, R. Gascoyne, G. Slack, 2013 .

International DLBCL Rituximab-CHOP Consortium Program demonstrates high-risk gene expression signatures: a report from The activated B-cell subtype of diffuse large B-cell lymphoma and MYC/BCL2 protein coexpression contributes to the inferior survival of

W. Choi, R. Gascoyne, G. Slack, 2013 .

International DLBCL Rituximab-CHOP Consortium Program demonstrates high-risk gene expression signatures: a report from The activated B-cell subtype of diffuse large B-cell lymphoma and MYC/BCL2 protein coexpression contributes to the inferior survival of

W. Choi, R. Gascoyne, G. Slack, 2013 .

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

W. Choi, R. Gascoyne, G. Slack, 2013 .

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

W. Choi, R. Gascoyne, G. Slack, 2013 .